deltatrials
Recruiting OBSERVATIONAL NCT06307938

Circulating Tumor DNA in Patients Summoned for Colonoscopy; - a Liquid Biopsy for Detection, Characterization, Individualized Treatment and Follow-up of Colorectal Cancer (CoLiQ)

Sponsor: Helse Nord-Trøndelag HF

Interventions liquid biopsy
Updated 4 times since 2024 Last updated: Apr 25, 2025 Started: Mar 10, 2025 Primary completion: May 31, 2026 Completion: May 31, 2028
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Colorectal Adenoma and Colorectal Cancer and is currently actively recruiting participants. Helse Nord-Trøndelag HF leads this study, which shows 4 recorded versions since 2025 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Apr 2024 – ~Jul 2024 · 3 months · monthly snapshotNot Yet Recruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~May 2025 · 8 months · monthly snapshotNot Yet Recruiting~May 2025 – present · 16 months · monthly snapshotRecruiting

Change History

4 versions recorded
  1. May 2025 — Present [monthly]

    Recruiting

    Status: Not Yet RecruitingRecruiting

  2. Sep 2024 — May 2025 [monthly]

    Not Yet Recruiting

  3. Jul 2024 — Sep 2024 [monthly]

    Not Yet Recruiting

  4. Apr 2024 — Jul 2024 [monthly]

    Not Yet Recruiting

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Helse Nord-Trøndelag HF
  • Norwegian University of Science and Technology
Data source: Helse Nord-Trøndelag HF

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations